Specific activity of myotube-synthesized F.IX
| . | [FIX] ELISA (mg/mL) . | Activity (U/mL) . | Specific activity (U/mg) . | % Normal . |
|---|---|---|---|---|
| PD-F.IX | 0.0222 | 3.74 | 167 | 84 |
| MS-F.IX sample 1 | 0.0037 | 0.515 | 136 | 68 |
| MS-F.IX sample 2 | 0.0097 | 1.72 | 177 | 89 |
| MS-F.IX sample 3 | 0.0005 | 0.0116 | 231 | 115 |
| MS-F.IX sample 4 | 0.0075 | 1.41 | 188 | 112 |
| Mean | 91 ± 12 |
| . | [FIX] ELISA (mg/mL) . | Activity (U/mL) . | Specific activity (U/mg) . | % Normal . |
|---|---|---|---|---|
| PD-F.IX | 0.0222 | 3.74 | 167 | 84 |
| MS-F.IX sample 1 | 0.0037 | 0.515 | 136 | 68 |
| MS-F.IX sample 2 | 0.0097 | 1.72 | 177 | 89 |
| MS-F.IX sample 3 | 0.0005 | 0.0116 | 231 | 115 |
| MS-F.IX sample 4 | 0.0075 | 1.41 | 188 | 112 |
| Mean | 91 ± 12 |
PD-F.IX, plasma-derived F.IX; MS-F.IX, myotube-synthesized F.IX.